[1]
Paolacci, S. et al. 2020. Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis. Acta Biomedica Atenei Parmensis. 91, 13-S (Nov. 2020), e2020009. DOI:https://doi.org/10.23750/abm.v91i13-S.10583.